Amicus Therapeutics, Inc.

Contributing Author

Recent Articles by Amicus Therapeutics, Inc.

6 hours	Amicus Therapeutics Announces Approval of Pombiliti (cipaglucosidase alfa) + Opfolda (miglustat) in Japan FOLD GlobeNewswire
Jun-03	New Analysis of Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat) Published in Muscle and Nerve FOLD GlobeNewswire
May-30	Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 FOLD GlobeNewswire
May-07	Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference FOLD GlobeNewswire